![]() ![]() |
Business ArchitectThrough an iterative process, we help reshape or refine the value proposition, market targets, business model, product development strategy and regulatory path needed to develop an actionable operating plan. Disruptive Market InnovatorMedStars specializes in creating new businesses with value pricing that disrupt existing markets. In addition to traditional patents, we craft business models into strong and sustainable barriers of entry. MentorMedStars coaches entrepreneurs and executives on how to navigate the challenges of building new business: prioritizing early stage milestones, developing and proving market driven value proposition, building organization, designing clear vision with actionable plans. Team BuilderMedStars has an extensive network to attract the right talent at the right time: Fund RaiserMedStars works closely with entrepreneurs to develop and implement their fund raising strategy:
Angel and Private InvestorsTo validate a technical proof of concept and market value proposition, we can act as lead investor and syndicate seed or series A financing with other angel groups. Check our articles about angel funding. We are active investors and part of the screening committees of Life Science Angels and HealthTech Capital. Venture CapitalAfter working with entrepreneurs to turn their concept into an attractive and exciting investment opportunity, we provide access to the most appropriate venture capital partners though our large and our well established network of venture capital firms. Corporate InvestorsWe work closely with entrepreneurs on the strategy, negotiation and implementation with large corporate investors or commercial partners. Testimonials
— Brian Rosenfeld, VISICU Co-founder, acquired by Philips
— Mike Breslow, VISICU Co-founder, acquired by Philips
— Ron Blum, CEO, Pixel Optics Inc.
— Robert Behl, Serial Entrepreneur (multiple medical device companies)
— Vicki E. Farrar, CEO, Catheter Connections, Inc.
— Dan Eckert, CEO, PolyRemedy, Inc.
— Nola E Masterson, Managing Director, Science Futures
— Stacey Burr, CEO, Textronics Inc., acquired by Adidas.
— Joseph D. Kittle, Jr, Ph.D., Chairman, Synthetic Biology Industry Association and Principle Virtual 3C Consulting
— Sarah Hine, CEO, PharmaSecure, Inc.
— Charles R. Cantor, CSO and Co-founder of Sequenom, member of the National Academy See All Testimonials |
|||||||||||
|
|||||||||||
|
Contact Us |
© 2009 MedStars. All rights reserved. Design by Night River |